1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. PRECISION BIOSCIENCES INC
Precision Biosciences Inc
XNAS: DTIL

Precision Biosciences Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for...

Read More
6.38 0.12 (1.92%)
27.66% Fall from 52W High
116.2K
XNAS Volume

XNAS 08 Apr, 2026 2:09 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
21.3 / 100
Momentum Score
Technically Neutral
54.2 / 100
Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM
Analyst Price Target
32
1Yr Price target upside is 402%
4 analysts

18

S

5

W

1

O

2

T

SWOT Analysis

Precision Biosciences Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..